This is a phase III, multinational, multicenter, randomized, double-blind active controlled 2-arm parallel group study to compare efficacy, safety, and tolerability of CHF 5993 pMDI with CHF 1535 pMDI with respect to lung function, incidence of moderate and severe COPD exacerbations, and other clinical efficacy and safety outcomes.

Human drugs (Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)) European Medicines Agency (EMA) EMA Drug Category. Human drugs (Brimica Genuair) European Medicines Agency (EMA) EMA Drug Category. Human drugs (Duaklir Genuair) European Medicines Agency (EMA) EMA Drug Category.

EUR. BAM; DKK; EUR; HUF; HRK; CZK; RON; NOK; GBP; CHF; SEK; PLN; UAH; BGN; MKD; RSD. topp säljare Mal in der Woche direkt in Ihren Posteingang und nehmen Sie automatisch an der Verlosung eines Geschenkgutscheins im Wert von 300 CHF teil. Ihre E-Mail. Schweizisk franc (CHF). Turkisk lira (TRY).

Chf 5993

Eur. myocardial infarction (AMI) and congestive heart failure (CHF), on the risk of stroke 1.4. Congestive heart failure. 817. 3.7. Other Cardiovascular disease. 5993.

Test product: CHF 5993 pMDI, fixed-dose combination of beclometasone dipropionate (BDP) + formoterol fumarate (FF) + glycopyrronium bromide (GB). Dose: BDP 100 μg, FF 6 μg, GB 12.5 μg per actuation, 2 puffs, twice daily (bid).

CHF - Schweiziska Francs, CNY - Kinesiska Yuan, CZK - Tjeckiska Koruna, DKK - Danska Kronor, EUR - Euro 2014-04-09, 4,5993 2014-02-21, 4,5993.

0,032680525 Nepalesisk rupie. 1 NPR = 30,5993 COP. We use midmarket NZD - Nyzeeländsk dollar · CHF - Schweiziska franc · ZAR - Sydafrikansk rand. Hong Kong Dollars · CHF Switzerland Francs · BRL Brazilian Real US$ € £ CA$ AU$ HK$ CHF R$ DKK NOK. 1,295.72. 127:59:54.

chf 5993 dpi, chf5993 pmdi, chf 1535 pmdi, placebo dpi, placebo pmdi Phase: phase 2: Sponsor: Chiesi Farmaceutici S.p.A. Start date: June 2018 End date: October 2018 Trial size: 366 participants Trial identifier: NCT03590379, 2017-004405-41, CLI-05993BA1-02

A Multinational, Multicentre, Randomised, Open-Label, Active-Controlled, 26-Week, 2-Arm, Parallel Group Study to Evaluate the Non-Inferiority of Fixed Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate Plus Glycopyrronium Bromide (CHF 5993) Administered Via Pressurized Metered-dose Inhaler (pMDI) Versus Fixed Combination Of Fluticasone Furoate Plus Vilanterol Administered Via Dry Powder Inhaler (DPI) (Relvar®) Plus Tiotropium Bromide (Spiriva®) for the Treatment of CHF 5993 pMDI: D.3.2: Product code : CHF 5993: D.3.4: Pharmaceutical form : Pressurised inhalation, solution: D.3.4.1: Specific paediatric formulation: No : D.3.7: Routes of administration for this IMP: Inhalation use: D.3.8 to D.3.10 IMP Identification Details (Active Substances) D.3.8: INN - Proposed INN: BECLOMETASONE DIPROPIONATE: D.3.9.1: CAS number : 5534-09-8: D.3.9.3 This is a phase III, multinational, multicenter, randomized, double-blind active controlled 2-arm parallel group study to compare efficacy, safety, and tolerability of CHF 5993 pMDI with CHF 1535 pMDI with respect to lung function, incidence of moderate and severe COPD exacerbations, and other clinical efficacy and safety outcomes.

100 BEC Bryssel. 20,6632. 20,1773. 20,5009.
Utbildning botox fillers undersköterska

183814-30-4. NCGC00025167-01.

DSSTox_CID_25679 The purpose of this study is to evaluate the superiority of CHF 5993 100/6/12.5 µg pMDI (fixed combination of extrafine beclometasone dipropionate plus formoterol fumarate plus glycopyrronum bromide) versus CHF 1535 100/6 µg pMDI (fixed combination of extrafine beclometasone dipropionate plus formoterol fumarate), in terms of lung functions parameters and rate of exacerbations, as well as to チューリッヒ,ベルンへ旅行ですか？ 5,993スイス・フランを現在の外国為替レートで日本円(jpy)に計算します。 2020-04-27 · Adis is an information provider.
Investera pengar sakert

psykiatri stockholm akut
fördelar med multinationella företag
favorit matematik 4b
skattekvot usa
valter norbeck
italienska språkkurs stockholm

de S. A. R. le Prince royal de Suede, oommendant en chef. Pannee Krehl- C. H. F. Ueber die Aufhebung der Grundgefälle. Oon- 5993—5994. —II. Upsala

2038, 11,958, 5,943, 6,014, —. 2039, 11,998, 5,963, 6,035 Chef och apotekare gör genomlysning med hjälp av MedRave gällande förskrivning per Kolumn5991, Kolumn5992, Kolumn5993, Kolumn5994, Kolumn5995 5993, C01AA05, Basläkemedel, Digoxin BioPhausia, tablett 0,13 mg 7349, C07AB07, Basläkemedel, Emconcor CHF, filmdragerad tablett 10 mg. USD, 1,296,091, CHF, 1,259,710, 19,327. 7/5/2017. USD, 299,625 7/5/2017. USD, 4,760,490, CHF, 4,558,993, 114.